Enterprise Software
Omnicell
Omnicell is a healthcare automation and pharmacy technology company providing medication management systems and software used by hospitals and pharmacies, anchored in a strategy of driving autonomous medication management via its cloud-native OmniSphere platform. Q1 2026 total revenue reached $310 million, up 15% year-over-year (20% product growth), with EPS beating estimates and non-GAAP EBITDA up 88%; the company booked its first Titan XT Automated Dispensing System orders in the quarter and maintained full-year 2026 revenue guidance of $1.215-1.255 billion.
Leading Indicators
Hiring and patent filing trends — the underlying numbers Momentum is computed from. Insider filing activity is tracked separately under Sources below.
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
3 sources · 51% avg. source confidence
- BusinessWire — Omnicell Q1 2026 revenue grows 15% to $310M54% source confidence
- Omnicell corporate site — Omnicell corporate overview46% source confidence
- StockTitan / Benzinga — Omnicell Q1 2026 EPS beats forecast, raises full-year EBITDA and EPS guidance54% source confidence
Latest Activity
Insider Filing Activity
Counts filing frequency only — transaction direction/size wasn't parseable from the sampled filings · sourced from SEC EDGAR · as of Jul 28, 2026
Dependency Map
What Omnicell depends on below, and who depends on Omnicell above — click any node to make it the new center, 3 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
The Story So Far (last 6 months)
Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.